HOME › DRUGS › BELANTAMAB MAFODOTIN-BLMF
ACTIVE SUBSTANCE / INN

BELANTAMAB MAFODOTIN-BLMF

Brand name(s): BLENREP
FDA LISTED
PRESCRIPTION
BLA761440
ACTIVE SUBSTANCE
Belantamab Mafodotin-Blmf
REGULATORS
FDA
SPONSORS / MAH
GLAXOSMITHKLINE LLC
TOTAL APPLICATIONS
1
FDA APPLICATIONS (DRUGS@FDA)
BRAND NAMEAPPLICATIONSPONSORSTATUS
BLENREPBLA761440GLAXOSMITHKLINE LLCPrescription

FULL INTELLIGENCE ON BELANTAMAB MAFODOTIN-BLMF

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →